DMT Models the Near-Death Experience
Christopher Timmermann, Leor Roseman, L. Williams, David Erritzøe, Charlotte Martial, Héléna Cassol, Steven Laureys, David Nutt, Robin Carhart-Harris
Frontiers in Psychology August 15, 2018 DOI: 10.3389/fpsyg.2018.01424 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Within-subjects placebo-controlled study Peer reviewed |
|---|---|
| Sample size | 13 |
| Population | Healthy participants |
| Intervention | DMT |
| Topics | DMT Near-death experience |
| Keywords | Placebo Trait Feeling Clinical psychology |
| Citations | 228 |
| Key points | DMT administration produced near-death experience phenomenology that significantly overlapped with features of actual NDEs. |
Abstract
Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT). Potential similarities between both subjective states have been noted previously, including the subjective feeling of transcending one's body and entering an alternative realm, perceiving and communicating with sentient 'entities' and themes related to death and dying. In this within-subjects placebo-controled study we aimed to test the similarities between the DMT state and NDEs, by administering DMT and placebo to 13 healthy participants, who then completed a validated and widely used measure of NDEs. Results revealed significant increases in phenomenological features associated with the NDE, following DMT administration compared to placebo. Also, we found significant relationships between the NDE scores and DMT-induced ego-dissolution and mystical-type experiences, as well as a significant association between NDE scores and baseline trait 'absorption' and delusional ideation measured at baseline. Furthermore, we found a significant overlap in nearly all of the NDE phenomenological features when comparing DMT-induced NDEs with a matched group of 'actual' NDE experiencers. These results reveal a striking similarity between these states that warrants further investigation.
In the evidence
This study is part of the evidence base for 2 syntheses in the library. Here is how each one recorded it.
-
State of the evidence: DMT Supports
DMT administration significantly increased near-death-experience phenomenology compared with placebo, with overlap in nearly all features versus actual NDE experiencers.
Synthesized
-
DMT produced significant increases in NDE phenomenology versus placebo, with substantial overlap in nearly all NDE features compared with actual experiencers.
Synthesized
Comparable studies
Other randomized controlled trials on near-death experience, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Virtual mortality and near-death experience after a prolonged exposure in a shared virtual reality may lead to positive life-attitude changes Female participants | 2018 | Randomized controlled trial | n = 31 |
| Effects of a Near-Death Experience Learning Module on Grief Bereaved adults (22 females, 2 males; aged 20-71 years, mean age 35.3 years) | 2010 | Randomized controlled trial | n = 24 |
| A virtual reality intervention to reduce death anxiety and stress in adults: examining the effect of a near-death experience simulation Adults | 2025 | Randomized controlled trial | n = 61 |
| Does Learning About Near-Death Experiences Promote Psycho-Spiritual Benefits in Those Who Have Not Had a Near-Death Experience? Adults (unspecified) randomly assigned to intervention or non-intervention group | 2017 | Randomized controlled trial | n = 143 |
Citations in the library
Cited by 155
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- Neural correlates of the DMT experience assessed with multivariate EEG. Scientific Reports November 19, 2019
- Human brain effects of DMT assessed via EEG-fMRI. Proceedings of the National Academy of Sciences March 28, 2023
- Psychedelics alter metaphysical beliefs. Scientific Reports November 23, 2021
- From many to (n)one: Meditation and the plasticity of the predictive mind. Neuroscience & Biobehavioral Reviews September 1, 2021
and 150 more in the library
Cites 68
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 63 more in the library